NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Vertex Pharmaceuticals dominates the market ... Sionna has mapped out a clinical trial strategy that could validate its different approach to the chronic respiratory disease.

Pain, as Vertex Pharmaceuticals found out ... Supporting Vertex’s case are a pair of large clinical trials that assessed Journavx in people who underwent either a “tummy tuck” or a bunion ...

Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.

In late-stage clinical trials, the drug reduced mean Numeric ... Keith Speights has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals.

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc ... providers who participated in the clinical trials and made this approval possible.

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter ... who participated in the clinical trials and made this approval possible. With these two recent approvals for ALYFTREK and ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

Lately, one of America's leading pharmaceutical companies can't catch ... it's only about as powerful as Vicodin tablets. In a clinical trial with patients who received a tummy tuck procedure ...

Vertex reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Trikafta/Kaftrio ...

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle ... the patients and healthcare providers who participated in the clinical trials and made ...